approved glp 1 Trends in the Development of GLP-1 Receptor Agonists Free Energy GLP-1 Medications: Everything You Need

That said, Germany remains deeply engaged with GLP-1 research, accounting for 12.4% of all global GLP-1 clinical trial activity in 2025, according to GlobalDatas trials database

Rare postmarketing reports of intestinal obstruction have also been noted

This aspect could reflect an altered action of ghrelin on its specific receptors implicated in feedback mechanisms.83 Regarding the role of CCK in inhibiting food intake, CCK-A receptor knockout rats are hyperphagic and obese.84 In animals, as expected, repeated preprandial administration of CCK reduces food intake but it also increases meal frequency, with no resulting effect on body weight.85 Circulating levels of PYY are not elevated in obese individuals

Immunizations Updates have been made to the "Immunizations" subsection to include changes related to COVID-19, pneumococcal pneumonia, influenza, and respiratory syncytial virus